# Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia

> **NCT01286649** · PHASE1,PHASE2 · COMPLETED · sponsor: **TrichoScience Innovations, Inc.** · enrollment: 19 (actual)

## Conditions studied

- Androgenetic Alopecia

## Interventions

- **OTHER:** Human autologous hair follicle cells
- **OTHER:** Cell medium

## Key facts

- **NCT ID:** NCT01286649
- **Lead sponsor:** TrichoScience Innovations, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2012-04
- **Final completion:** 2017-02-23
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2017-03-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01286649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01286649, "Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01286649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*